Origin Bancorp (NASDAQ:OBNK) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.88 by 2.27 percent. This is a 23.08 percent decrease over earnings of $1.17 per share from the same period last year.
Actinium Activates Radiation Inside the Body for Target Conditioning of Cancer Cells
Actinium Pharmaceuticals Inc. (NYSE: ATNM), a clinical-stage biopharmaceutical company, is developing antibody radiation-conjugates (ARCs) to combine the targeting ability of antibodies with the cell-killing ability of radiation.